Orexo to Feature at 15th Annual Healthcare Conference 2024
![Orexo to Feature at 15th Annual Healthcare Conference 2024](https://investorshangout.com/images/blog/ihnews-Orexo%20to%20Feature%20at%2015th%20Annual%20Healthcare%20Conference%202024.jpg)
Orexo to Attend Pareto Securities' 15th Annual Healthcare Conference
Orexo AB (Publ.), renowned for its pharmaceutical innovations, is excited to share that it will take part in the upcoming Pareto Securities' 15th Annual Healthcare Conference. This prestigious event is scheduled to occur soon, providing a platform for industry leaders to discuss advancements in healthcare.
Event Details and Presentation Insights
The conference will be held at the Downtown Camper by Scandic, located at Brunkebergstorg 9. During the event, Robert Rönn, Orexo's Senior Vice President and Head of R&D, will present details about the company's innovative journey and future directions on the day. This presentation is set for the time slot of 2:25 to 2:45 PM CET in the Event Small room. Attendees will also have the opportunity to meet individually with Robert Rönn and Lena Wange, the Director of Investor Relations.
About Orexo: A Leader in Pharmaceutical Innovation
With almost three decades of experience, Orexo has positioned itself as a premier Swedish pharmaceutical company. The company focuses on creating advanced treatment options that address significant health challenges. Orexo concentrates on developing drugs to tackle opioid use disorders while also exploring new therapeutic areas in partnership with leading firms around the globe. In the last reported fiscal year, Orexo achieved remarkable sales totaling SEK 624 million and operates with a dedicated workforce of 126 employees. As a publicly listed entity on Nasdaq Stockholm's main exchange, Orexo also trades on the OTCQX under the ticker ORXOY in the United States.
Innovative Technology: AmorphOX®
One of Orexo's groundbreaking technological advancements is AmorphOX, a sophisticated drug delivery system aimed at enhancing the effectiveness of medications. This unique formulation involves a mix of drugs and carrier materials that come together to form a stable powder. The resulting particles possess superb chemical stability and facilitate quick dissolution, proving highly effective for a diverse range of active substances. Clinical studies have validated its utility, demonstrating expanded absorption and rapid release of drugs into the system.
Contact Information for Orexo
For further inquiries, please reach out to Orexo's IR & Communications Director, Lena Wange, who can be contacted at +46 18 780 88 00 or via email at Lena.Wange@orexo.com.
Stay Connected with Orexo
To explore more about Orexo and its trailblazing products, visit www.orexo.com. For the latest news and updates, follow Orexo on social media platforms like X, LinkedIn, and YouTube.
Frequently Asked Questions
1. What is the purpose of Orexo's participation in the conference?
Orexo aims to showcase its latest innovations in pharmaceutical treatments and engage with industry stakeholders.
2. Who will be representing Orexo at the conference?
Robert Rönn, Senior Vice President and Head of R&D, along with Director of Investor Relations, Lena Wange.
3. What innovative technology does Orexo utilize for drug delivery?
Orexo employs AmorphOX® technology, enhancing drug stability and absorption efficiency.
4. How can I learn more about Orexo's products and updates?
You can visit Orexo's official website at www.orexo.com and follow their social media channels.
5. What is the significance of this conference for Orexo?
This conference is an opportunity for Orexo to network, share insights, and discuss advancements within the pharmaceutical sector.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Vitamins Market to Reach US$15.87 Billion by 2033
- Shortwave Infrared Market Growth Expected to Reach USD 350 Million
- Growth Prospects: ESR Analyzers Market Expected to Expand
- Blackwell 3D Advances Corporate Growth and Asian Expansion Plans
- LanzaTech Partners with SEKISUI for Waste-to-Ethanol Innovation
- REMSleep Secures Patent Approval for Nasal Ventilation System
- RadNet, Inc. to Present at an Upcoming Healthcare Conference
- Join the Class Action Against Lululemon Athletica Inc. Today
- NANO Nuclear Energy Inc. Class Action Lawsuit Update for Investors
- Class Action Lawsuit Notice for SeaStar Medical Investors
- Symbotic Inc. Investors Alert: Class Action Lawsuit Notice
- Current Legal Action Against Stellantis N.V. Investors - STLA
- Legal Action Initiated for Ford Motor Company (F) Investors
- Markets Responding to Harris Opposition on U.S. Steel Deal
- Orthofix Medical Inc. Faces Class Action: Important Investor Update
- Partners Group Shares Drop as Earnings Miss Expectations
- MacroGenics, Inc. Investors Encouraged to Contact Legal Team
- Vicor Corporation Faces Class Action Lawsuit: Key Insights
- Top Value Stocks for a Stronger Q3 Performance Ahead
- Levi & Korsinsky Urges Investors in Walgreens - Act Before Deadline
- Rolls-Royce Stock Rises Amid Cathay Pacific Engine Review
- Seritage Growth Properties Investors Alert: Class Action Lawsuit Update
- Barclays Upgrades Deutsche Bank to Overweight Amid Optimism
- Class Action Alert: MongoDB Investors Urged to Act Before Deadline
- Bitcoin's Recent Surge: Economic Data and Fed Decisions Ahead
Recent Articles
- Global Equities Experience Continued Selling Pressure in Markets
- ThermTec Unveils Innovative Wild-D Series Thermal Monocular
- ThermTec Unveils Wild-D Series: The Future of Hunting Tech
- China and South Africa Collaborate for Enhanced Trade Growth
- Orexo's Upcoming Participation in Annual Healthcare Conference
- Scania Unveils Next-Gen 13-Litre Marine Engine for Sustainability
- Sampo plc Announces Latest Share Buyback Details
- 3 Demons Performance and Joey Kramer Unite for Veterans
- LG Forms Consortium in China for Advanced Heat Pump Research
- Valneva and Pfizer Announce Positive Lyme Disease Vaccine Results
- Volkswagen Considers Closure of German Factories for First Time
- CWA Ends Mediation with AT&T Amid Ongoing Strike Action
- Cardano's Charles Hoskinson Questions Bitcoin's Longevity
- Smart Infrastructure Market Estimated to Reach $2.04 Trillion
- Check Point Software Launches Game-Changing MSSP Portal
- Thermal Ceramics Market Growth: Insights and Trends
- Vaxcyte Webcast: Results of VAX-31 Vaccine Study
- Ferrari N.V. Updates on Share Buyback Program Activities
- Market Outlook Ahead of Key Jobs Report
- Management Trading Insights: Understanding Company Actions
- Understanding Total Voting Rights of Alliance Trust PLC
- Investing Insights: Navitas Semiconductor's Growth Potential
- Growing Demand Drives Paper Dyes Market to $1.42 Billion
- Color Cosmetics Market Growth Driven by Organic Demand
- Comparing Dividends: AT&T vs Verizon Analysis